Loading asset research
Filana Therapeutics Inc. Common Stock
FLNANasdaq · USD · StocksQuote as of · Exchange session not verified$0.77
-4.94%
Today
FLNA
Loading 1D prices…
Market cap
$37.3M
Volume
309.6K
52w high
$4.9852w low
$0.75Company profile
Filana Therapeutics Inc. Common Stock
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Austin, TX, United States
Employees
17
Fiscal year end
1231
CIK
1069530
Session & valuation
Open$0.81
Previous close$0.81
Day high$0.81
Day low$0.77
30-day avg. volume281K
Outstanding shares48.3M
Diluted EPS-$1.88
Latest annual period
P/E (trailing)-0.41
P/E (forward)—
Price / book0.59
Beta-0.70
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LITSLite Strategy Inc. Common Stock | $37.8M | $0.00 | — | -$1.68 | +4.72% | Hold |
| KPTIKaryopharm Therapeutics Inc. Common Stock | $36.5M | $146.1M | -134.21% | -$17.93 | -1.23% | Buy |
| CRVOCervoMed Inc. Common Stock | $38.9M | $4M | -673.15% | -$2.98 | +3.63% | Buy |
| IXHLIncannex Healthcare Inc. Common Stock | $39M | $86K | -19547.67% | -$1.51 | +0.31% | Hold |
| NSRXNasus Pharma Ltd. Ordinary Shares | $39.9M | $1.2B | -0.47% | -$0.72 | +1.64% | Buy |